Skip to main content
. 2016 Nov 7;7(49):81661–81669. doi: 10.18632/oncotarget.13163

Table 1. Clinical characteristics of the study subjects (N = 219).

Age (year) 52.0 (46.0, 59.0)
Left breast cancer 112 (51.1%)
Right breast cancer 107 (48.9%)
Max diameter of cancer (cm) 2.2 (1.5, 3.0)
Invasive lobular carcinoma 9 (4.1%)
Invasive ductal carcinoma 210 (95.9%)
Axillary lymph node metastasis 91 (41.6%)
ER+ 147 (67.1%)
PR+ 143 (65.3%)
HER-2+ 52 (23.7%)
Ki67 30.0% (15.0%, 50.0%)
Luminal A 39 (17.8%)
Luminal B 95 (43.4%)
HER-2 overexpression 53 (24.2%)
ER-, PR- and Her-2- 32 (14.6%)

Abbreviations: Continuous variables are presented as median (with interquartile range); categorical variables are presented as number (percentage). ER+, estrogen receptor positive; PR+, progesterone receptor positive; HER-2+, human epidermal growth factor receptor-2 positive; Ki67, Ki67 nuclear antigen.